Synereca Pharmaceuticals' Unattributed Round

Synereca Pharmaceuticals raised a round of funding on August 15, 2017.

Synereca Pharmaceuticals was created to address the growing problem of bacterial resistance to current antibiotics by developing orally active drugs that restore or increase the effectiveness of exist…

Articles about Synereca Pharmaceuticals' Unattributed Round: